Diabetes Mellitus Type 2 Perspective

• A New Reason to Be Wary of SGLT2s   Exceedingly serious adverse events in patients taking these hypoglycemic agents have been reported. Which are the culprit drugs?
  Medscape Internal Medicine, September 2018
• Is an Antiaging Drug Around the Corner? Medscape speaks with aging researcher Dr Nir Barzilai about genetic contributors to lifespan and promising treatments to extend human life.
  Medscape Public Health, September 2018
• The Latest Attack on Low-Carb Diets: Science or Politics? A recent paper in Lancet Public Health announced that low-carb diets are associated with increased mortality. But are the study's conclusions based on sound scientific evidence?
  Medscape Diabetes & Endocrinology, September 2018
• New AAFP Recs: Pelvics, Glucose Checks, Transfusions; More   Other items on the list: herpes, testicular cancer, and scoliosis screening.
  Medscape Internal Medicine, September 2018
• Top News From ESC 2018: Slideshow Headlines from the world's largest cardiology meeting include surprising negative trials of fish oil supplements and aspirin for cardiovascular prevention.
  Medscape News Slideshows, September 2018
• Anti-VEGF Effective in Persistent Diabetic Macular Edema A recent analysis associated three different anti-VEGF agents with meaningful vision gains through 2 years of follow-up.
  Medscape Ophthalmology, September 2018
• Primary Prevention in Diabetes: Is Aspirin the Answer?   We've heard a lot about aspirin lately, but what do we know about aspirin in patients with diabetes?
  Medscape Internal Medicine, September 2018
• Diabetes Patients Beg, Ration Insulin in Cost Crisis The high cost of insulin is driving some patients to reuse supplies and hoard insulin, with serious health implications -- sometimes even death.
  Medscape Diabetes & Endocrinology, September 2018
• Who Is the 'Cardiometabolic Specialist'?   With new diabetes drugs available that lower cardiovascular risk, the question arises over which specialty will manage this area of medicine. Or will a new specialty emerge?
  Medscape Diabetes & Endocrinology, September 2018
• Anti-VEGF vs PRP for Proliferative Diabetic Retinopathy Five-year data from DRCR.net Protocol S provides needed comparative data on the efficacy, safety, and burden of these treatments.
  Medscape Ophthalmology, September 2018
• ESC 2018Aspirin in Primary Prevention: Lessons From ASCEND   The ESC hotline ASCEND trial on low-dose aspirin for primary CV prevention in people with diabetes is reviewed with presenter Prof Armitage.
  theheart.org on Medscape, September 2018
• Diabetes Technology Advances: It's a Whole New World for Kids   There are myriad technology advances that are making the management of diabetes in children both easier and more complicated.
  CHOP Expert Commentary, August 2018
• ESC 2018Fish Oils Off the Menu for People With Diabetes   Prof Bowman discusses the ASCEND findings on omega-3 fatty acids for cardiovascular prevention in people with type 2 diabetes, presented at the European Society of Cardiology congress.
  theheart.org on Medscape, August 2018
• ESC 2018Aspirin in Primary Prevention: Lessons From ARRIVE   The ARRIVE trial compared low-dose aspirin with placebo in middle-aged men and women at moderate CV risk. Investigator J. Michael Gaziano gives John Mandrola the details.
  theheart.org on Medscape, August 2018
• 'Unique' NICE Guidelines Have Clinician and Patient in Mind   Drs Shubrook and Wilding discuss the unique attributes of the NICE guideline for care of patients with type 2 diabetes.
  Medscape Family Medicine, August 2018
• Diabetes' Costs in Time and Treasure   A recent survey asked patients with diabetes about both the financial and personal costs of the disease.
  Medscape Family Medicine, August 2018
• AI in Ophthalmology: A Brave New World Coming There's a lot of hype about autonomous artificial intelligence systems, but are they anywhere near ready for prime time?
  Medscape Ophthalmology, August 2018
• Is One Basal Insulin Just Like Another?   A new review suggests that we may be fooling ourselves by rating one high-priced insulin over another.
  Medscape Internal Medicine, August 2018
• Sulfonylureas: Just Stop   Sulfonylureas are commonly prescribed despite their known risks.
  Medscape Internal Medicine, August 2018
• 5 Dietary Tips to Share With Your Patients With the constant barrage of nutrition and diet advice, it's difficult to know what 'healthy eating' really means. Here are five simple evidence-based tips to share when counseling your patients.
  Medscape, August 2018